The paper "Startup & Unicorn Growth Valuation" by Andreas A. Aigner and Walter Schrabmair, published on November 10, 2020, provides a comprehensive method for valuing recently IPOed companies with strong price trends. The authors introduce the growth average U1 as a tool to accurately assess the health of this growth. By analyzing financials and tracking revenue and earnings trends, they determine whether the growth is robust or weak. The paper suggests using the Rule of 40 to measure company health by calculating revenue growth. To eliminate seasonality effects and obtain a more accurate picture of performance, trailing twelve-month running values for total revenue and gross profit are used. The example of Crowdstrike (CRWD) illustrates how these metrics are updated at different intervals and emphasizes the importance of consistent tracking. By calculating a linear regression through these data points, investors can estimate annual growth more effectively. Overall, "Startup & Unicorn Growth Valuation" offers valuable insights for making informed decisions in today's dynamic market environment.
- - The paper provides a method for valuing recently IPOed companies with strong price trends
- - Introduces the growth average U1 as a tool to assess growth health
- - Suggests using the Rule of 40 to measure company health by calculating revenue growth
- - Uses trailing twelve-month running values for total revenue and gross profit to eliminate seasonality effects
- - Illustrates the importance of consistent tracking through the example of Crowdstrike (CRWD)
- - Recommends calculating linear regression through data points to estimate annual growth effectively
Summary1. The paper shows how to figure out the value of new companies that are doing well in the stock market.
2. It introduces a new way called growth average U1 to check if a company is growing well.
3. To see if a company is healthy, we can use the Rule of 40 by looking at how much their revenue is growing.
4. By using numbers from the past year, we can compare companies without being affected by seasonal changes.
5. Tracking progress regularly is important, as shown with the example of Crowdstrike.
Definitions- IPOed: When a company starts selling its shares on the stock market for the first time.
- Assess: To look at something carefully and decide how good or bad it is.
- Revenue: The money a company makes from selling goods or services.
- Gross profit: The money left after subtracting the cost of making or buying products from total revenue.
- Seasonality effects: Changes in business performance caused by different seasons of the year.
- Linear regression: A way to predict future values based on past data points.
Introduction
The world of startups and unicorns, companies with a valuation of over $1 billion, has been gaining significant attention in recent years. With the rise of technology and innovation, these high-growth companies have become increasingly attractive to investors looking for potential big returns. However, accurately valuing these companies can be a challenging task due to their unique characteristics and fast-paced growth.
In November 2020, Andreas A. Aigner and Walter Schrabmair published a research paper titled "Startup & Unicorn Growth Valuation," which provides a comprehensive method for valuing recently IPOed companies with strong price trends. The authors introduce the growth average U1 as a tool to assess the health of this growth accurately. In this blog post, we will delve into the key findings and insights from this paper.
The Growth Average U1
One of the main contributions of this research paper is introducing the concept of growth average U1 as an essential metric for evaluating startup and unicorn growth. This metric takes into account both revenue and earnings trends to determine whether the company's growth is robust or weak.
To calculate U1, financials are analyzed over three periods: current year (t), previous year (t-1), and two years ago (t-2). The formula for calculating U1 is:
U1 = ((Revenue(t)/Revenue(t-2)) + (Earnings(t)/Earnings(t-2))) / 4
This formula considers both absolute values (revenue) as well as relative values (earnings) to provide a more holistic view of company performance. By using four data points instead of just two, it eliminates any distortions caused by seasonality effects or short-term fluctuations.
The Rule of 40
Another valuable insight from this paper is using the Rule of 40 to measure company health by calculating revenue growth. The Rule of 40 states that a company's revenue growth rate and EBITDA (earnings before interest, taxes, depreciation, and amortization) margin should add up to at least 40%. This rule helps investors evaluate whether a company is growing at a healthy pace while also maintaining profitability.
To apply the Rule of 40, the authors suggest using trailing twelve-month running values for total revenue and gross profit. This approach eliminates any seasonality effects and provides a more accurate picture of the company's performance.
Case Study: Crowdstrike (CRWD)
The paper uses the example of Crowdstrike, a cybersecurity company that went public in June 2019, to illustrate how these metrics are updated at different intervals. The authors track U1 over four quarters since its IPO date and compare it with other key financial indicators such as revenue growth rate and EBITDA margin.
The results show that U1 has been consistently above zero for all four quarters, indicating strong growth for Crowdstrike. However, there have been fluctuations in both revenue growth rate and EBITDA margin during this period. By calculating a linear regression through these data points, investors can estimate annual growth more effectively.
This case study highlights the importance of consistent tracking of key metrics to get an accurate understanding of company performance over time.
Conclusion
In today's dynamic market environment where startups and unicorns are gaining significant attention from investors, accurately valuing these companies is crucial. "Startup & Unicorn Growth Valuation" by Andreas Aigner and Walter Schrabmair offers valuable insights into evaluating recently IPOed companies with strong price trends.
By introducing the concept of U1 as a tool to assess growth health and using the Rule of 40 to measure overall company health, this paper provides practical methods for making informed investment decisions. The case study on Crowdstrike further emphasizes the importance of consistent tracking and analysis of key metrics.
Overall, this research paper is a valuable resource for investors looking to navigate the world of startups and unicorns and make informed decisions in today's fast-paced market.